Key result
FISH identifying MDM2 and DDIT3 coamplification without rearrangement supports diagnosing ALT/WDL with myxoid stroma.
Why the study?
Diagnosis of ALT/WDL can be challenging due to morphologic overlap with benign adipose lesions and other liposarcoma subtypes, complicating diagnosis and management of orbital liposarcoma.
Case Report (n=1)
Molecular genetic studies are crucial in differentiating atypical lipomatous tumor/well-differentiated liposarcoma with myxoid stroma from myxoid liposarcoma in orbital tumors.
Molecular profiling may refine orbital lipomatous tumor classification; leaves open validation in larger cohorts before routine adoption.
Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) is an indolent, locally aggressive mesenchymal neoplasm, most often confined to the lower extremities and retroperitoneum and rarely identified in the orbit. Diagnosis of ALT/WDL can be challenging due to its frequent morphologic overlap with benign adipose lesions and other more aggressive liposarcoma subtypes, including myxoid liposarcoma. We describe a 26-year-old female with a history of hereditary retinoblastoma and external-beam radiotherapy to the orbit, who developed orbital liposarcoma. Although initial morphologic assessment raised the consideration of myxoid liposarcoma, subsequent fluorescein in situ hybridization studies demonstrated MDM2 and DDIT3 coamplification without DDIT3 rearrangement, supporting the diagnosis of ALT/WDL with myxoid stroma. The literature review of previously reported orbital myxoid liposarcomas revealed a morphologic overlap of documented tumors with ALT/WDL, dedifferentiated liposarcoma, and pleomorphic liposarcoma with myxoid stroma as well as an absence of immunohistochemical and molecular genetic data supportive of the diagnosis of myxoid liposarcoma. This case emphasizes the potential overlap of ALT/WDL with myxoid liposarcoma and the increasing importance of molecular genetic studies in the diagnosis, prognosis, and management of orbital liposarcoma.
No takes yet. Share an insight, caveat, or question.
Peck et al. (2019) conducted a case report in Orbital liposarcoma (Atypical lipomatous tumor/well-differentiated liposarcoma) (n=1). Fluorescein in situ hybridization (FISH) studies was evaluated on Diagnosis of ALT/WDL with myxoid stroma. Fluorescein in situ hybridization studies demonstrating MDM2 and DDIT3 coamplification without DDIT3 rearrangement supported the diagnosis of ALT/WDL with myxoid stroma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: